THALES
Thales, the cybersecurity leader that protects critical applications, APIs, and data, anywhere at scale, today announced the release of the 2024 Imperva Bad Bot Report, a global analysis of automated bot traffic across the internet. Nearly half (49.6%) of all internet traffic came from bots in 2023—a 2% increase over the previous year, and the highest level Imperva has reported since it began monitoring automated traffic in 2013.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240416225637/en/
©Thales
For the fifth consecutive year, the proportion of web traffic associated with bad bots grew to 32% in 2023, up from 30.2% in 2022, while traffic from human users decreased to 50.4%. Automated traffic is costing organizations billions (USD) annually due to attacks on websites, APIs, and applications.
“Bots are one of the most pervasive and growing threats facing every industry,” says Nanhi Singh, General Manager, Application Security at Imperva, a Thales company. “From simple web scraping to malicious account takeover, spam, and denial of service, bots negatively impact an organization’s bottom line by degrading online services and requiring more investment in infrastructure and customer support. Organizations must proactively address the threat of bad bots as attackers sharpen their focus on API-related abuses that can lead to account compromise or data exfiltration.”
Key trends identified in the 2024 Imperva Bad Bot Report include:
- Global average of bad bot traffic reached 32%: Ireland (71%), Germany (67.5%), and Mexico (42.8%), saw the highest levels of bad bot traffic in 2023. The US also saw a slightly higher ratio of bad bot traffic at 35.4% compared to 2022 (32.1%).
- Growing use of generative AI connected to the rise in simple bots: Rapid adoption of generative AI and large language models (LLMs) resulted in the volume of simple bots increasing to 39.6% in 2023, up from 33.4% in 2022. The technology uses web scraping bots and automated crawlers to feed training models, while enabling nontechnical users to write automated scripts for their own use.
- Account takeover is a persistent business risk: Account takeover (ATO) attacks increased 10% in 2023, compared to the same period in the prior year. Notably, 44% of all ATO attacks targeted API endpoints, compared to 35% in 2022. Of all login attempts across the internet, 11% were associated with account takeover. The industries that saw the highest volume of ATO attacks in 2023 were Financial Services (36.8%), Travel (11.5%), and Business Services (8%).
- APIs are a popular vector for attack: Automated threats caused a significant 30% of API attacks in 2023. Among them, 17% were bad bots exploiting business logic vulnerabilities—a flaw within the API’s design and implementation that allows attackers to manipulate legitimate functionality and gain access to sensitive data or user accounts. Cybercriminals use automated bots to find and exploit APIs, which act as a direct pathway to sensitive data, making them a prime target for business logic abuse.
- Every industry has a bot problem: For a second consecutive year, Gaming (57.2%) saw the largest proportion of bad bot traffic. Meanwhile, Retail (24.4%), Travel (20.7%), and Financial Services (15.7%) experienced the highest volume of bot attacks. The proportion of advanced bad bots, those that closely mimic human behavior and evade defenses, was highest on Law & Government (75.8%), Entertainment (70.8%), and Financial Services (67.1%) websites.
- Bad bot traffic originating from residential ISPs grows to 25.8%: Early bad bot evasion techniques relied on masquerading as a user agent (browser) commonly used by legitimate human users. Bad bots masquerading as mobile user agents accounted for 44.8% of all bad bot traffic in the past year, up from 28.1% just five years ago. Sophisticated actors combine mobile user agents with the use of residential or mobile ISPs. Residential proxies allow bot operators to evade detection by making it appear as if the origin of the traffic is a legitimate, ISP-assigned residential IP address.
“Automated bots will soon surpass the proportion of internet traffic coming from humans, changing the way that organizations approach building and protecting their websites and applications,” continued Singh. “As more AI-enabled tools are introduced, bots will become omnipresent. Organizations must invest in bot management and API security tools to manage the threat from malicious, automated traffic.”
Additional Information:
- Download a copy of the 2024 Imperva Bad Bot Report for additional insights.
- See how Imperva Advanced Bot Protection, API Security, and Client-Side Protection can protect websites, mobile applications, and APIs from automated attacks and fraud without affecting the flow of business-critical traffic.
- Read the Imperva Blog for the latest product and solution news, and threat intelligence from Imperva Threat Research.
About Thales
Thales (Euronext Paris: HO) is a global leader in advanced technologies within three domains: Defence & Security, Aeronautics & Space, and Digital Identity & Security. It develops products and solutions that help make the world safer, greener and more inclusive.
The Group invests close to €4 billion a year in Research & Development, particularly in key areas such as quantum technologies, Edge computing, 6G and cybersecurity.
Thales has 81,000* employees in 68 countries. In 2023, the Group generated sales of €18.4 billion.
* These figures exclude the ground transportation business, which is being divested
PLEASE VISIT
Cloud Protection & Licensing Solutions | Thales Group
Cybersecurity Solutions | Thales Group
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240416225637/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Presents New Data on Benefits of ALYFTREK® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 18:00:00 CEST | Press release
- Oral presentation on outcomes following treatment with CFTR modulators show that improvements in CFTR function, as measured by lower sweat chloride, correlate with better outcomes for people with cystic fibrosis - - Oral presentation on new post hoc data from randomized, controlled and open-label trials suggest improved quality of life results with ALYFTREK compared to TRIKAFTA® – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conferenc
Andersen Consulting tilføjer dimension med David and Golyat6.6.2025 16:33:00 CEST | Pressemeddelelse
Andersen Consulting udbygger sin globale konsulentkapacitet gennem en samarbejdsaftale med David and Golyat, en filippinsk konsulentvirksomhed inden for digital strategi. Med et stærkt fokus på business intelligence, kundeindsigt og digital first-eksekvering arbejder David and Golyat med kunder på tværs af flere sektorer – herunder regeringer, udviklingsorganisationer og private virksomheder – for at skabe langsigtet værdi gennem datainformerede beslutninger. Miko David, administrerende partner i David and Golyat, siger: "Vi ser frem til samarbejdet med Andersen Consulting, da det er en milepæl i vores vækstforløb. Ved at kombinere vores ekspertise inden for digital strategi og Andersen Consultings globale platform er vi i stand til at levere endnu større værdi til kunder, der navigerer på komplekse markeder." "Dette samarbejde betyder, at vi kan tilføre en ekstra dimension til vores globale konsulentplatform," siger Mark L. Vorsatz, global bestyrelsesformand og administrerende direktø
IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10th Anniversary Year of NAHYCO® Technology6.6.2025 16:00:00 CEST | Press release
IBSA Derma, the dermoaesthetic division of Swiss company IBSA, will participate in the 18th IMCAS Asia Congress in Bangkok, gathering over 3,000 professionals from across the region to explore the future of aesthetic and regenerative medicine.With the presence in the Congress and a dedicated scientific symposium, the company reaffirms its commitment to advancing bioremodeling approaches and promoting a holistic, science-driven vision of authentic beauty.This year marks a key milestone for IBSA Derma: 10 years of NAHYCO® Technology, a patented innovation in hyaluronic acid science that continues to shape the future of tissue regeneration. IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the
HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors6.6.2025 14:00:00 CEST | Press release
Pivotal Study Advances to Establish Histotripsy as a Non-Thermal, Surgery-Free Alternative to Destroy and Liquefy Kidney Tumors HistoSonics, Inc., the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the completion of patient enrollment in its pivotal #HOPE4KIDNEY trial. This prospective, multi-center, single-arm trial is designed to evaluate the safety and effectiveness of the Edison System in destroying kidney tissue by treating primary solid kidney tumors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606659747/en/ Edison Histotripsy System Procedure for Kidney Tumor Animation The trial enrolled patients with a single, non-metastatic solid kidney mass ≤3 cm, confirmed by imaging and biopsy. Subjects will be followed for five years post-procedure, with evaluations at multiple time points, including 14-day, 30-day, 90-day, 180-day, and annual assessments. The Edison
Norwegian Tech Firm Builds Military Command Center in 24 Hours6.6.2025 13:45:00 CEST | Press release
Norwegian technology provider Cyviz has successfully developed a fully mobile and ballistic-proof command center - designed, configured, and made operational in just 24 hours. The solution was showcased during a military exercise led by the Dutch Ministry of Defence and has already sparked interest from NATO members and civil protection agencies across Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606640770/en/ Cyviz demonstrates rapid deployment capability with a mobile, container-based control room for defense and crisis response Cyviz and its partners constructed the command room inside a 14-ton container designed for transport on standard military vehicles and resistant to machine gun fire. The unit was deployed at a military base in the Netherlands, where Cyviz was tasked with delivering a fully functional command-and-control environment, under strict time constraints and in a high-stakes simulation. "You do
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom